Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Bio-Techne Q1 Adj. EPS $0.42, Inline, Sales $286.555M Miss $290.867M Estimate

Author: Benzinga Newsdesk | November 05, 2025 06:31am
Bio-Techne (NASDAQ:TECH) reported quarterly earnings of $0.42 per share which met the analyst consensus estimate. This is unchanged from the same period last year. The company reported quarterly sales of $286.555 million which missed the analyst consensus estimate of $290.867 million by 1.48 percent. This is a 1.00 percent decrease over sales of $289.458 million the same period last year.

Posted In: TECH


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist